稳健医疗：公司持续推进GRI的整合工作

Core Viewpoint - The company reported that its subsidiary GRI faced challenges due to the US-China trade war, impacting its supply chain and leading to losses in Q2, but overall profitability was maintained in the first half of the year [1] Group 1: Financial Performance - GRI experienced a direct impact on its supply chain after March, resulting in a halt of exports to the US from April to June, which contributed to losses in Q2 [1] - Despite the challenges, GRI achieved overall profitability in the first half of the year [1] Group 2: Future Outlook - The supply chain for GRI has fully recovered, with improved operational performance in July and strong order momentum in August, attributed to customer confidence in its US-based factory and nearshore production in the Dominican Republic [1] - Orders began to increase gradually from June, indicating a positive trend for the second half of the year [1] - Future performance of GRI is expected to align closely with initial cash flow forecasts made at the time of acquisition, with a focus on enhancing operational efficiency and profitability [1] Group 3: Integration and Strategy - The company is actively working on the integration of GRI, reaching consensus on organizational structure, digitalization, smart manufacturing upgrades, and overseas supply chain layout [1] - Plans are in place to further advance these initiatives in the second half of the year, with strong confidence in GRI's future performance [1]